Big Gain For InMed Pharmaceuticals Inc.
Fri, Sep 09, 2022 at 07:23 PM
InMed Pharmaceuticals Inc. (INM:NASDAQ) rocketted at $11.02, representing a gain of 24.2%. On Fri, Sep 09, 2022, INM:NASDAQ hit a New 2-Week High of $11.02. The stock appeared on our News Catalysts scanner on Fri, Sep 09, 2022 at 06:05 PM in the 'PRIVATE PLACEMENT' category. From Fri, Aug 26, 2022, the stock recorded 77.78% Up Days and 20.00% Green Days
About InMed Pharmaceuticals Inc. (INM:NASDAQ)
InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company.
Top 10 Gainers:
- Digital Media Solutions Inc. Class A (DMS:NYSE), 71.88%
- Aditxt Inc. (ADTX:NASDAQ), 37%
- Trinity Place Holdings Inc. (TPHS:NYSEMKT), 33.79%
- American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 31.09%
- MOGU Inc. (MOGU:NYSE), 29.82%
- Shuttle Pharmaceuticals Holdings Inc. (SHPH:NASDAQ), 26.14%
- Invitae Corporation (NVTA:NYSE), 25%
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 24.24%
- Xilio Therapeutics Inc. (XLO:NASDAQ), 22.77%
- Veru Inc. (VERU:NASDAQ), 21.93%